Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Fanselow

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Pharmacology|August 9, 1988
Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin testD J Calcagnetti, F J Helmstetter, M S Fanselow
Pharmacology, Biochemistry, and Behavior|February 1, 1989
Delta opioid antagonist, 16-Me cyprenorphine, selectively attenuates conditional fear- and DPDPE-induced analgesia on the formalin testM S Fanselow, D J Calcagnetti, F J Helmstetter
Hippocampus|March 23, 2001
Hippocampus and contextual fear conditioning: recent controversies and advancesS G Anagnostaras, G D Gale, M S Fanselow
Behavioral Neuroscience|February 1, 1994
NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposureS L Young, D L Bohenek, M S Fanselow
Pharmacology, Biochemistry, and Behavior|January 1, 1990
Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solutionD J Calcagnetti, R L Calcagnetti, M S Fanselow
Physiology & Behavior|January 1, 1987
Effects of cerebellar vermal lesions on species-specific fear responses, neophobia, and taste-aversion learning in ratsW F Supple, R N Leaton, M S Fanselow
Behavioral Neuroscience|December 1, 1993
Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fearJ J Kim, R A Rison, M S Fanselow
Hippocampus|September 4, 2001
Cholinergic modulation of pavlovian fear conditioning: effects of intrahippocampal scopolamine infusionG D Gale, S G Anagnostaras, M S Fanselow
Neurobiology of Learning and Memory|March 1, 1995
Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioningS L Young, D L Bohenek, M S Fanselow
Behavioral Neuroscience|June 1, 1989
Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266M S Fanselow, D J Calcagnetti, F J Helmstetter
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Pharmacology|August 9, 1988
Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin testD J Calcagnetti, F J Helmstetter, M S Fanselow
Pharmacology, Biochemistry, and Behavior|February 1, 1989
Delta opioid antagonist, 16-Me cyprenorphine, selectively attenuates conditional fear- and DPDPE-induced analgesia on the formalin testM S Fanselow, D J Calcagnetti, F J Helmstetter
Hippocampus|March 23, 2001
Hippocampus and contextual fear conditioning: recent controversies and advancesS G Anagnostaras, G D Gale, M S Fanselow
Behavioral Neuroscience|February 1, 1994
NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposureS L Young, D L Bohenek, M S Fanselow
Pharmacology, Biochemistry, and Behavior|January 1, 1990
Centrally administered opioid antagonists, nor-binaltorphimine, 16-methyl cyprenorphine and MR2266, suppress intake of a sweet solutionD J Calcagnetti, R L Calcagnetti, M S Fanselow
Physiology & Behavior|January 1, 1987
Effects of cerebellar vermal lesions on species-specific fear responses, neophobia, and taste-aversion learning in ratsW F Supple, R N Leaton, M S Fanselow
Behavioral Neuroscience|December 1, 1993
Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fearJ J Kim, R A Rison, M S Fanselow
Hippocampus|September 4, 2001
Cholinergic modulation of pavlovian fear conditioning: effects of intrahippocampal scopolamine infusionG D Gale, S G Anagnostaras, M S Fanselow
Neurobiology of Learning and Memory|March 1, 1995
Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioningS L Young, D L Bohenek, M S Fanselow
Behavioral Neuroscience|June 1, 1989
Modulation of appetitively and aversively motivated behavior by the kappa opioid antagonist MR2266M S Fanselow, D J Calcagnetti, F J Helmstetter
Pageof 9